JP2019530750A5 - - Google Patents

Download PDF

Info

Publication number
JP2019530750A5
JP2019530750A5 JP2019539737A JP2019539737A JP2019530750A5 JP 2019530750 A5 JP2019530750 A5 JP 2019530750A5 JP 2019539737 A JP2019539737 A JP 2019539737A JP 2019539737 A JP2019539737 A JP 2019539737A JP 2019530750 A5 JP2019530750 A5 JP 2019530750A5
Authority
JP
Japan
Prior art keywords
therapeutically effective
free amino
preparation according
amino acids
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019539737A
Other languages
English (en)
Japanese (ja)
Other versions
JP7267546B2 (ja
JP2019530750A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/055167 external-priority patent/WO2018067717A1/en
Publication of JP2019530750A publication Critical patent/JP2019530750A/ja
Publication of JP2019530750A5 publication Critical patent/JP2019530750A5/ja
Priority to JP2023060554A priority Critical patent/JP7593577B2/ja
Application granted granted Critical
Publication of JP7267546B2 publication Critical patent/JP7267546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019539737A 2016-10-04 2017-10-04 アミノ酸組成物及びその使用 Active JP7267546B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023060554A JP7593577B2 (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662403965P 2016-10-04 2016-10-04
US62/403,965 2016-10-04
US201662421443P 2016-11-14 2016-11-14
US62/421,443 2016-11-14
PCT/US2017/055167 WO2018067717A1 (en) 2016-10-04 2017-10-04 Amino acid compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023060554A Division JP7593577B2 (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Publications (3)

Publication Number Publication Date
JP2019530750A JP2019530750A (ja) 2019-10-24
JP2019530750A5 true JP2019530750A5 (enExample) 2020-11-12
JP7267546B2 JP7267546B2 (ja) 2023-05-02

Family

ID=61831937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019539737A Active JP7267546B2 (ja) 2016-10-04 2017-10-04 アミノ酸組成物及びその使用
JP2023060554A Active JP7593577B2 (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023060554A Active JP7593577B2 (ja) 2016-10-04 2023-04-04 アミノ酸組成物及びその使用

Country Status (9)

Country Link
US (1) US11576884B2 (enExample)
EP (1) EP3522882A4 (enExample)
JP (2) JP7267546B2 (enExample)
CN (2) CN115645388B (enExample)
AU (1) AU2017338887B2 (enExample)
BR (1) BR112019006742A2 (enExample)
CA (2) CA3135553C (enExample)
MX (1) MX2019003821A (enExample)
WO (1) WO2018067717A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030970B8 (ru) 2010-09-24 2019-01-31 Юниверсити Оф Флорида Рисёч Фаундейшн, Инк. Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения
EP4417256A3 (en) 2013-03-11 2024-10-23 University of Florida Research Foundation, Inc. Materials and methods for improving lung function
US20230255916A1 (en) * 2016-10-04 2023-08-17 University Of Florida Research Foundation, Inc. Amino acid compositions and uses thereof
JP2021520351A (ja) * 2018-04-04 2021-08-19 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 皮膚を治療するための組成物
WO2020028129A1 (en) * 2018-07-30 2020-02-06 Almeda Labs Llc Cardioprotective amino acid formulations
RU2709502C1 (ru) * 2019-09-23 2019-12-18 Виктор Александрович Сисев Фармацевтическая композиция для парентерального капельного введения
WO2021142514A1 (en) * 2020-01-13 2021-07-22 Monash University Compositions and methods
JP7470376B2 (ja) * 2020-03-31 2024-04-18 国立大学法人山口大学 顎下腺の萎縮抑制剤及び創傷治癒促進剤
IL299488A (en) * 2020-07-02 2023-02-01 Univ Florida Preparations for promoting hydration and methods of using them
CN114097952A (zh) * 2020-08-28 2022-03-01 河北科星药业有限公司 毛丝鼠专用的营养添加剂、其制备方法及应用
JP2025501331A (ja) * 2022-01-03 2025-01-17 エントリンジック,エルエルシー スキンケアのための製剤及び方法
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein
CN117085142A (zh) * 2023-08-04 2023-11-21 中山大学附属第七医院(深圳) 一种负载小分子药物的间充质干细胞外泌体及其制备方法与应用
CN117159520B (zh) * 2023-08-17 2026-04-07 中国人民解放军海军军医大学第一附属医院 竹红菌甲素在制备抑制胰腺纤维化的药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016758A1 (en) 1991-03-05 1994-08-04 Miris Medical Corporation A medication cassette for an automatic aerosol medication delivery system
WO1993000951A1 (en) 1991-07-02 1993-01-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
CA2210499A1 (en) 1995-02-23 1996-08-29 Novartis Nutrition Ag Amino acid compositions and use thereof in a clinical nutrition
AU5806998A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
AU776679B2 (en) 1998-11-13 2004-09-16 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
CA2557814A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
US20070010459A1 (en) 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US8691213B2 (en) * 2006-08-04 2014-04-08 SHS International Protein free formula
BRPI0814745A2 (pt) 2007-08-03 2014-10-07 Aminotech As Composição de produto.
JP5576097B2 (ja) * 2009-11-17 2014-08-20 大塚製薬株式会社 気道抵抗改善剤
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397023B1 (it) * 2009-11-27 2012-12-20 Professional Dietetics Srl Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva
BR112012016869A2 (pt) 2010-01-08 2015-09-01 President And Fellows Harvard College Método e revestimentos para tratar biofilmes.
EA030970B8 (ru) 2010-09-24 2019-01-31 Юниверсити Оф Флорида Рисёч Фаундейшн, Инк. Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
EP2793813A1 (en) * 2011-12-21 2014-10-29 Motolese, Pasquale Cosmetic composition and uses thereof in the treatment of lipodystrophies
EA034014B1 (ru) 2012-02-08 2019-12-19 Юниверсити Оф Флорида Рисёч Фаундейшн, Инк. Способ лечения субъекта с диареей, вызванной ротавирусом
EP4417256A3 (en) * 2013-03-11 2024-10-23 University of Florida Research Foundation, Inc. Materials and methods for improving lung function
DE102013224993A1 (de) * 2013-12-05 2015-06-11 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit substituierten Silikon(en)
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
CN107106527B (zh) * 2014-11-24 2020-11-24 恩特林斯科健康解决方案股份公司 用于治疗疾病症状的氨基酸组合物

Similar Documents

Publication Publication Date Title
JP2019503365A5 (enExample)
JP2020033360A5 (enExample)
JP2015517489A5 (enExample)
JP2017528507A5 (enExample)
WO2007109118A3 (en) RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
JP2010518122A5 (enExample)
CN111989095A (zh) 预防或治疗肿瘤疗法副作用的方法
KR20160093000A (ko) 창자 과투과성을 치료하기 위한 티로신 하이드록실라제 억제제
JP2020521797A5 (enExample)
JP2013510169A5 (enExample)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
JP2014050390A5 (enExample)
JP2020524689A5 (enExample)
CN102186496A (zh) 治疗肾功能紊乱的组合物和方法
MX2020007971A (es) Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar.
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2023518356A5 (enExample)
PT2285393E (pt) Composições para o tratamento de distúrbios do tracto respiratório superior e síndromes gripais
JP2009505979A5 (enExample)
CN108366981A (zh) 用于治疗与间质性肺病相关的咳嗽的甲磺司特
HRP20211488T1 (hr) Sastav i metoda za liječenje metaboličkih poremećaja
JP2023531872A5 (enExample)
JP2009542609A5 (enExample)
JP2008533079A5 (enExample)
RU2016116955A (ru) Гидробромидная соль n-(4-хлор-2-гидрокси-3-((3s)-3-пиперидинилсульфонил)фенил)-n'-(3-фтор-2-метилфенил)мочевины